TherapeuticsMD (TXMD) Asset Utilization Ratio (2011 - 2026)

TherapeuticsMD's Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.09 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 86.54% year-over-year to 0.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09 (up 86.54% YoY) and the FY2025 annual result came in at 0.08, up 84.29% from the prior year.
• Asset Utilization Ratio was 0.09 for Q1 2026 at TherapeuticsMD, up from 0.08 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.33 in Q3 2023 and bottomed at 0.03 in Q2 2024.
• A 5-year average of 0.33 and a median of 0.08 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 830.44% — and 2024, when it slumped 97.89%.
• TherapeuticsMD's Asset Utilization Ratio stood at 0.62 in 2022, then tumbled by 95.3% to 0.03 in 2023, then surged by 53.28% to 0.04 in 2024, then surged by 76.21% to 0.08 in 2025, then advanced by 12.56% to 0.09 in 2026.
• Business Quant data shows TXMD's Asset Utilization Ratio at 0.09 in Q1 2026, 0.08 in Q4 2025, and 0.07 in Q3 2025.